Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain
Lynn R. Webster(Adherent Technologies (United States)), William P. Forbes(Bausch Health (United States)), Enoch Bortey(Bausch Health (United States)), A. P. Barrett(Cooperative Institute for Research in Environmental Sciences), Craig Paterson(Bausch Health (United States)), Darren M. Brenner(Northwestern University)
Cited by 21
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Changes in Arctic melt season and implications for sea ice loss
|Geophysical Research Letters|2014|776
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331
Sleep-Disordered Breathing and Chronic Opioid Therapy
|Pain Medicine|2007|309